The natural history of secondary progressive multiple sclerosis
- PMID: 20639385
- DOI: 10.1136/jnnp.2010.208173
The natural history of secondary progressive multiple sclerosis
Abstract
Background: The onset of secondary progression is a pivotal event in the course of relapsing-remitting (RR) multiple sclerosis (MS). Patients with secondary progressive MS (SPMS) experience continuous worsening of symptoms independent of the occurrence of relapses. Possible risk factors associated with the onset of SPMS remain under investigated in natural history studies of MS disease course.
Methods: We used Kaplan-Meier survival analyses and Cox regression models to investigate the influence of gender, onset age and onset symptoms on time to and age at SPMS in British Columbia (BC) MS patients with a RR disease onset who were not exposed to immunomodulatory drugs.
Results: Of 5778 patients in the BCMS database with definite MS, 5207 (90%) had an RR onset. Median time to SPMS was 21.4 years (95% CI 20.6 to 22.2), reached at a median age of 53.7 years (95% CI 53.1 to 54.3). Male gender and motor onset symptoms were associated with a shorter time to and a younger age at SPMS. A younger age at disease onset was associated with a longer time to SPMS but also with a younger age at secondary progression. Other onset symptoms were not associated with time to, or age at, SPMS.
Conclusions: We identified three factors influencing the onset of SPMS in untreated patients with RRMS: motor onset symptoms and male gender were associated with both a shorter time to and a younger age at SPMS. A younger age at disease onset should not be viewed as indicating a better prognosis.
Comment in
-
Progression is likely to occur earlier in young men with motor onset symptoms.J Neurol Neurosurg Psychiatry. 2010 Sep;81(9):944-5. doi: 10.1136/jnnp.2010.213942. Epub 2010 Jul 2. J Neurol Neurosurg Psychiatry. 2010. PMID: 20601669 No abstract available.
Similar articles
-
Natural history of secondary-progressive multiple sclerosis.Mult Scler. 2008 Apr;14(3):314-24. doi: 10.1177/1352458507084264. Epub 2008 Jan 21. Mult Scler. 2008. PMID: 18208898
-
Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities.J Neurol. 2009 Mar;256(3):374-81. doi: 10.1007/s00415-009-0039-7. Epub 2009 Mar 18. J Neurol. 2009. PMID: 19308306
-
Secondary progressive multiple sclerosis - clinical course and potential predictive factors.Neurol Neurochir Pol. 2008 Jan-Feb;42(1):6-11. Neurol Neurochir Pol. 2008. PMID: 18365957
-
A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.J Steroid Biochem Mol Biol. 2016 Nov;164:254-257. doi: 10.1016/j.jsbmb.2015.11.009. Epub 2015 Nov 17. J Steroid Biochem Mol Biol. 2016. PMID: 26598277 Review.
-
Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.Mult Scler Relat Disord. 2021 May;50:102778. doi: 10.1016/j.msard.2021.102778. Epub 2021 Jan 28. Mult Scler Relat Disord. 2021. PMID: 33592384 Review.
Cited by
-
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA).J Neurol. 2024 Oct;271(10):6801-6810. doi: 10.1007/s00415-024-12621-9. Epub 2024 Aug 27. J Neurol. 2024. PMID: 39190108 Free PMC article.
-
Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta-analysis.Ann Clin Transl Neurol. 2024 Sep;11(9):2236-2253. doi: 10.1002/acn3.52165. Epub 2024 Jul 28. Ann Clin Transl Neurol. 2024. PMID: 39073308 Free PMC article.
-
The evolving contribution of MRI measures towards the prediction of secondary progressive multiple sclerosis.J Neurol Neurosurg Psychiatry. 2024 Jul 22:jnnp-2024-333917. doi: 10.1136/jnnp-2024-333917. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39038948
-
Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study.Heliyon. 2024 Jun 15;10(12):e32946. doi: 10.1016/j.heliyon.2024.e32946. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38984301 Free PMC article.
-
Sex-driven variability in TSPO-expressing microglia in MS patients and healthy individuals.Front Neurol. 2024 Feb 20;15:1352116. doi: 10.3389/fneur.2024.1352116. eCollection 2024. Front Neurol. 2024. PMID: 38445263 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources